Point of Care Infectious Disease Testing Market
According to Intent Market Research, the Point of Care Infectious Disease Testing Market is expected to grow from USD 10.9 billion in 2024-e at a CAGR of 5.4% to touch USD 14.9 billion by 2030. The Point of Care Infectious Disease Testing Market is dominated by key players such as Abbott Laboratories, Roche Diagnostics, Thermo Fisher Scientific Inc., Danaher Corporation, Siemens Healthineers, BD (Becton, Dickinson, and Company), Bio-Rad Laboratories, Cepheid, Quidel Corporation, Hologic Inc., Alere Inc. (Now part of Abbott), MedMira Inc., Chembio Diagnostics, Inc., Mettler-Toledo International, Inc., Labcorp